In a murine model, administration of bortezomib, a proteasome inhibitor, in dorsal root ganglion induced painful neuropathy by phosphorylating signal transducer and activator of transcription-3 (STAT3) and acetylation of histone H3 and H4 in the NLRP3 promoter region. Here, STAT3 is linked to neuropathy.